1993
DOI: 10.1016/0300-9084(93)90043-r
|View full text |Cite
|
Sign up to set email alerts
|

Tissue protein turnover in animals treated with the mixed β-agonist metaproterenol: Influence of dose, route and pattern of administration

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
1
0

Year Published

1995
1995
2013
2013

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(1 citation statement)
references
References 16 publications
0
1
0
Order By: Relevance
“…Experiments have been carried out in several species to find out whether an increased rate of protein synthesis contributes to the muscle hypertrophy induced by ␤ 2 -agonist administration (4,19). The results obtained in vivo have been conflicting because of differences in the technique used for measurement of protein synthesis and in the experimental design, such as dose, route of drug administration, and timing of measurements (26). The finding in some experiments that muscle protein synthesis was not affected in clenbuteroltreated animals (28) led to the suggestion that the muscle hypertrophy induced by the ␤ 2 -agonist is exclusively dependent on the inhibiton of protein degradation.…”
mentioning
confidence: 99%
“…Experiments have been carried out in several species to find out whether an increased rate of protein synthesis contributes to the muscle hypertrophy induced by ␤ 2 -agonist administration (4,19). The results obtained in vivo have been conflicting because of differences in the technique used for measurement of protein synthesis and in the experimental design, such as dose, route of drug administration, and timing of measurements (26). The finding in some experiments that muscle protein synthesis was not affected in clenbuteroltreated animals (28) led to the suggestion that the muscle hypertrophy induced by the ␤ 2 -agonist is exclusively dependent on the inhibiton of protein degradation.…”
mentioning
confidence: 99%